Johnathan Goree

Professor

UAMS

Last publication 2026 Last refreshed 2026-05-16

faculty

Anesthesiology, College of Medicine

14 h-index 69 pubs 1,028 cited

Research Areas

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Dr. Johnathan Goree's research focuses on the treatment of chronic pain conditions, particularly utilizing minimally invasive procedures and advanced neuromodulation techniques. He has published extensively on the efficacy of high-frequency (10-kHz) spinal cord stimulation for various refractory pain conditions, including painful diabetic neuropathy and non-surgical refractory back pain. His work has investigated the durability and health-related quality of life improvements associated with this treatment modality, with publications detailing 12-month and 24-month results from randomized controlled trials.

Beyond spinal cord stimulation, Dr. Goree's interests extend to the management of complex regional pain syndrome and the analysis of gait in patients with degenerative spine conditions. He is also involved in developing consensus guidelines for interventional pain management, as evidenced by his contributions to guidelines for cancer-associated pain and knee pain. Dr. Goree collaborates with several researchers at the University of Arkansas for Medical Sciences, including Erika Petersen and Gregory L. Smith, with whom he has co-authored numerous publications.

Academically, Dr. Goree holds board certifications in anesthesiology and pain medicine. He completed his medical degree and residency at Weill College of Medicine at Cornell University and a fellowship in interventional pain management at Emory University Hospital. His scholarly output includes 69 publications and a citation count of 983, with an h-index of 14, reflecting his active contributions to the field of pain medicine.

Research Overview

Board certified in anesthesiology and pain medicine, Dr. Johnathan Goree is a proud alumnus of Catholic High School in Little Rock, Arkansas. He received his Bachelor of Arts in biology from Washington University in St. Louis. He then moved to New York City where he completed both his medical degree and residency in anesthesiology at the Weill College of Medicine at Cornell University. Following his time in Manhattan, he completed a fellowship in interventional pain management at Emory University Hospital in Atlanta, Georgia. In 2014, Dr. Goree returned home to Little Rock, Arkansas to join the faculty at UAMS where he serves as the Director of Interventional Pain Management Services and an Assistant Professor in the Department of Anesthesiology. He primarily focuses on the treatment of chronic pain conditions using minimally invasive procedures. His specific research interests include gait analysis in patients with degenerative spine conditions and treatment of complex regional pain syndrome.

Metrics

h-index: 14
Publications: 69
Citations: 1,028

Selected Publications

Correction: Next‑Generation SCS Programming Platform: Enhancing ECAP Fidelity and Objectivity to Improve Patient Experience (2026)

DOI OpenAlex
Next-Generation SCS Programming Platform: Enhancing ECAP Fidelity and Objectivity to Improve Patient Experience (2026)

DOI OpenAlex
Clinical utility of ECAP dosing in a real-world population delivered via EVOKE therapy: the ECAP study (2025)

1 citation DOI OpenAlex
ID# 1906098 ECAP Study Premiere: Real-World IDE Study Showing Relationship between Physiologic ECAP Biomarkers and Pain Outcomes (2025)

DOI OpenAlex
ECAP-Controlled Closed-Loop Spinal Cord Stimulation for Chronic Nonsurgical Refractory Back Pain (2025)

1 citation DOI OpenAlex
Exploring Racial Disparities in Chronic Pain Management (2025)

2 citations DOI OpenAlex
The American Society of Pain and Neuroscience (ASPN) Guidelines and Consensus on the Definition, Current Evidence, Clinical Use and Future Applications for Physiologic Closed-Loop Controlled Neuromodulation in Chronic Pain: A NEURON Group Project (2025)

5 citations DOI OpenAlex
Objective, physiologic, biometrically driven spinal cord stimulation trialing is a necessity—The length of the trial is not (2025)

2 citations DOI OpenAlex
Restorative Neurostimulation Therapy Compared to Optimal Medical Management: A Randomized Evaluation (RESTORE) for the Treatment of Chronic Mechanical Low Back Pain due to Multifidus Dysfunction (2025)

12 citations DOI OpenAlex
High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy (2024)

7 citations DOI OpenAlex
ID: 342895 Assessment of Psychosocial Factors and Success of Neuromodulation Trials for Treatment of Persistent Pain (2024)

DOI OpenAlex
ID: 314772 10 kHz SCS Treatment of Painful Diabetic Neuropathy: Significant Reductions in HbA1c, Weight, and Pain (2024)

DOI OpenAlex
Maximal Analgesic Effect Attained by the Use of Objective Neurophysiological Measurements With Closed-Loop Spinal Cord Stimulation (2024)

17 citations DOI OpenAlex
Identifying SCS Trial Responders Immediately After Postoperative Programming with ECAP Dose-Controlled Closed-Loop Therapy (2024)

9 citations DOI OpenAlex
Randomized Placebo-Controlled Trial of 60-Day Percutaneous Peripheral Nerve Stimulation Treatment Indicates Relief of Persistent Postoperative Pain, and Improved Function After Knee Replacement (2024)

23 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

Junior Faculty Development Award: Chronic Pain and its Influence on Mental Health in Older Adults. HRSA Geriatric Workforce Enhancement Program, Geriatric Fellowship from AR Geriatric Education Collaborative (AGEC) Principal Investigator
No FP attached UAMS Intramural Grant (CTSA) Principal Investigator
No FP attached UAMS Intramural Grant (CTSA) Principal Investigator
A Sequenced Strategy for Improving Outcomes in People with Knee Osteoarthritis Pain (SKOAP) (IRB 274236) NIH/Nat. Inst. of Arthritis & Musculoskeletal & Skin Diseases - Pass Through: Johns Hopkins University Principal Investigator
A multicenter Phase 1 double-blind, randomized, sham-controlled dose escalation study to determine safety and tolerability of single dose intrathecal ST-503 gene therapy for refractory pain due to idiopathic small fiber neuropathy (iSFN) (IRB 298950) Sangamo Therapeutics - Pass Through: CTI Clinical Trial Services, Inc. Principal Investigator
Improving Emergency Department Management of Acute and Chronic Pain Using Non-Opioid Strategies Substance Abuse & Mental Health Services Administration - Pass Through: Substance Abuse & Mental Health Services Administration Principal Investigator
A Sequenced Strategy for Improving Outcomes in People with Knee Osteoarthritis Pain (SKOAP) (IRB 274236) NIH/Nat. Inst. of Arthritis & Musculoskeletal & Skin Diseases - Pass Through: Johns Hopkins University Principal Investigator
Medical Student Anesthesia Research Fellowship (MSARF) The Foundation for Anesthesia Education and Research (FAER) Principal Investigator